172 related articles for article (PubMed ID: 21565479)
1. Management of metabolic syndrome in children and adolescents.
Pacifico L; Anania C; Martino F; Poggiogalle E; Chiarelli F; Arca M; Chiesa C
Nutr Metab Cardiovasc Dis; 2011 Jun; 21(6):455-66. PubMed ID: 21565479
[TBL] [Abstract][Full Text] [Related]
2. Treatment of metabolic syndrome.
Wagh A; Stone NJ
Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):213-28. PubMed ID: 15151470
[TBL] [Abstract][Full Text] [Related]
3. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.
Harden KA; Cowan PA; Velasquez-Mieyer P; Patton SB
J Am Acad Nurse Pract; 2007 Jul; 19(7):368-77. PubMed ID: 17680902
[TBL] [Abstract][Full Text] [Related]
4. Treating the metabolic syndrome.
Bianchi C; Penno G; Romero F; Del Prato S; Miccoli R
Expert Rev Cardiovasc Ther; 2007 May; 5(3):491-506. PubMed ID: 17489673
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and treatment of metabolic syndrome in adolescents with type 2 diabetes.
Sanders BH; Lubsch LM; West DS
Ann Pharmacother; 2006 Sep; 40(9):1517-21. PubMed ID: 16896016
[TBL] [Abstract][Full Text] [Related]
6. Obesity and metabolic syndrome: potential benefit from specific nutritional components.
Abete I; Goyenechea E; Zulet MA; MartÃnez JA
Nutr Metab Cardiovasc Dis; 2011 Sep; 21 Suppl 2():B1-15. PubMed ID: 21764273
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome: are we at risk?
Paudel B
Nepal Med Coll J; 2007 Sep; 9(3):204-11. PubMed ID: 18092442
[TBL] [Abstract][Full Text] [Related]
8. Obesity and cardiometabolic syndrome in children.
Velasquez-Mieyer P; Neira CP; Nieto R; Cowan PA
Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):61-81. PubMed ID: 19124396
[TBL] [Abstract][Full Text] [Related]
9. [Non-alcoholic fatty liver disease in children: a new complication of obesity].
Bocca G; Stolk RP; Scheenstra R; Sauer PJ
Ned Tijdschr Geneeskd; 2008 Nov; 152(45):2443-7. PubMed ID: 19051794
[TBL] [Abstract][Full Text] [Related]
10. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention.
Misra A; Khurana L
Metab Syndr Relat Disord; 2009 Dec; 7(6):497-514. PubMed ID: 19900153
[TBL] [Abstract][Full Text] [Related]
11. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
[TBL] [Abstract][Full Text] [Related]
12. The current unmet need in type 2 diabetes mellitus: addressing glycemia and cardiovascular disease.
Levy P
Postgrad Med; 2009 May; 121(3 Suppl 1):7-12. PubMed ID: 19494472
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance, diabetes and cardiovascular risk: approaches to treatment.
Rosenberg DE; Jabbour SA; Goldstein BJ
Diabetes Obes Metab; 2005 Nov; 7(6):642-53. PubMed ID: 16219008
[TBL] [Abstract][Full Text] [Related]
14. Secular trends in variables associated with the metabolic syndrome of North American children and adolescents: a review and synthesis.
Eisenmann JC
Am J Hum Biol; 2003; 15(6):786-94. PubMed ID: 14595870
[TBL] [Abstract][Full Text] [Related]
15. Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial.
Fontbonne A; Diouf I; Baccara-Dinet M; Eschwege E; Charles MA
Diabetes Metab; 2009 Nov; 35(5):385-91. PubMed ID: 19665415
[TBL] [Abstract][Full Text] [Related]
16. Childhood obesity and its health consequence in China.
Li Y; Yang X; Zhai F; Piao J; Zhao W; Zhang J; Ma G
Obes Rev; 2008 Mar; 9 Suppl 1():82-6. PubMed ID: 18307705
[TBL] [Abstract][Full Text] [Related]
17. Increasing prevalence of obesity and clustered cardiometabolic risk: can treatment of the underlying cause reverse the trends?
Ballantyne CM
Crit Pathw Cardiol; 2007 Jun; 6(2):41-5. PubMed ID: 17667863
[TBL] [Abstract][Full Text] [Related]
18. Management issues in the metabolic syndrome.
Deedwania PC; Gupta R
J Assoc Physicians India; 2006 Oct; 54():797-810. PubMed ID: 17214277
[TBL] [Abstract][Full Text] [Related]
19. The effect of metformin on the incidence of type 2 diabetes mellitus and cardiovascular disease risk factors in overweight and obese subjects--the Carmos study.
Andreadis EA; Katsanou PM; Georgiopoulos DX; Tsourous GI; Yfanti GK; Gouveri ET; Diamantopoulos EJ
Exp Clin Endocrinol Diabetes; 2009 Apr; 117(4):175-80. PubMed ID: 19053032
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
Boppidi H; Daram SR
Postgrad Med; 2008 Jul; 120(2):E01-7. PubMed ID: 18654060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
